Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".

Show more authors
+ 2
Simone N Koole
Philip C Schouten
Willemien J van Driel
Gabe S Sonke
Sabine C Linn

More about this publication

International journal of cancer

Volume 151
Issue nr. 11
Pages 2057-2058
Publication date 01-12-2022

Full text links

Publisher website (DOI) 10.1002/ijc.34219
Europe PubMed Central 35857410
Pubmed 35857410

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.